Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion

Metabolism: Clinical and Experimental

Volumn 52, Issue 8, 2003, Pages 1038-1042

  Wägner, Ana M ^a,b   Ordóñez Llanos, Jordi ^a,b   Arcelus, Rosa ^a,b   Bonet, Rosa ^a,b   Jorba, Oscar ^a,b   Sánchez Quesada, Jose L ^a,b   Alonso, Esther ^a,b   Julve, Josep ^a,b   Pérez, Antonio ^a  

^a HOSPITAL SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL PALMITATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0042386761     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00090-8     Document Type: Article

References (29)

1. Stamler J, Vaccaro O, Neaton JD, et al: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
2. Syvänne M, Taskinen MR: Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350(suppl 1):20-23, 1997
3. Wägner AM, Pérez A, Calvo F, et al: Apolipoprotein B identifies dyslipidaemic phenotypes associated with cardiovascular risk in normocholesterolaemic type 2 diabetic patients. Diabetes Care 22:812-817, 1999
4. Austin MA, Breslow JL, Hennekens CH, et al: Low density lipoprotein subclass pattern and risk of myocardial infarction. JAMA 250:1917-1921, 1988
5. Groot PHE, Van Stiphout WAHJ, Krauss XH, et al: Postprandial lipoprotein metabolism in normolipidaemic men with and without coronary artery disease. Arteriosclerosis 11:653-670, 1991
6. Karpe F, Steiner G, Uffelman K, et al: Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106:83-97, 1994
7. Lewis GF, O'Meara NM, Soltys PA, et al: Fasting hypertriglyceridaemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72:934-944, 1991
8. Tan KCB, Cooper MB, Ling KLE, et al: Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: The involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113:273-287, 1995
9. Cavallero E, Dachet C, Neufcour D, et al: Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: Relationship to postprandial lipemia and C-peptide/glucagon levels. Metabolism 43:270-278, 1994
10. Reznik Y, Pousse P, Herrou M, et al: Postprandial lipoprotein metabolism in normotriglyceridaemic non-insulin dependent diabetic patients: Influence of apolipoprotein E polymorphism. Metabolism 45:63-71, 1996
11. Attia N, Durlach V, Paul J-L, et al: Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridaemic non-insulin-dependent diabetic subjects. Atherosclerosis 113:197-200, 1995
12. Lottenberg SA, Lottenberg AMP, Nunes VS, et al: Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II and normal controls. Atherosclerosis 127:81-90, 1996
13. Durlach V, Attia N, Zahouani A, et al: Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridaemic non-insulin-dependent diabetic patients. Atherosclerosis 120:155-165 1996
14. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
15. Ruotolo G, Zhang H, Bentsianov V, et al: Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. J Lipid Res 22:1541-1549, 1992
16. Matthews J, Altman D, Campbell M, et al: Analysis of serial measurements in medical research. BMJ 300:230-235, 1990
17. Nichols AV, Krauss RM, Musliner TA: Nondenaturating polyacrylamide gradient gel electrophoresis, In: Segret JP, Albers LL (eds): Methods in Enzymology: Plasma Lipoproteins. New York, NY, Academy Press, 1986, pp 417-431
18. Peinado-Onsurbe J, Soler C, Soley M, et al: Lipoprotein lipase and hepatic lipase activities are differentially regulated in isolated hepatocytes from neonatal rats. Biochim Biophys Acta 1125:82-89, 1992
19. Coulliard C, Bergeron N, Bergeron J, et al: Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations. J Clin Endocrinol Metab 85:4575-4582, 2000
20. Krasinski SD, Cohn JS, Russell RM, et al: Postprandial plasma vitamin A metabolism in humans: A reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 39:357-365, 1990
21. Pirro M, Lupattelli G, Siepi D, et al: Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women. Metabolism 50:330-334, 2001
22. Vakkilainen J, Jauhiainene M, Ylitalo K, et al: LDL particle size in familial combined hyperlidipemia: Effects of serum lipids, lipoprotein-modifying enzymes and lipid transfer proteins. J Lipid Res 43:598-603, 2002
23. Baynes C, Henderson AD, Anyaoku V, et al: The role of insulin insensitivity and hepatic lipase in the dyslipidemia of type 2 diabetes. Diabetic Med 8:560-566, 1991
24. Kasim SE, Tseng K, Jen KLC, et al: Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus. J Clin Endocrinol Metab 65:183-187, 1987
25. Halkes CJM, Castro Cabezas M, Wijk JPH, et al: Obesity overrules the beneficial effects on triglyceride metabolism in non-obese subjects. Atherosclerosis 151:97, 2000 (abstr)
26. Furuya D, Yagihashi A, Nasu S, et al: LDL particle size by gradient-gel electrophoresis cannot be estimated by LDL-cholesterol/apolipoprotein B ratios. Clin Chem 46:1202-1203, 2000
27. Griffin BA, Minihane AM, Furlonger N, et al: Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin Sci 97:269-276, 1999
28. Wägner AM, Jorba O, Rigla M, et al: LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol 39:215-220, 2002
29. Wägner AM, Pérez A, Blanco-Vaca F, et al: Inaccuracy of calculated LDL cholesterol in type 2 diabetes: Consequences for patient risk classification and therapeutic decision. Clin Chem 46:1830-1832, 2000